Botulinum Toxin-A in Dystonia

J Gordon Millichap

doi:10.15844/pedneurbriefs-4-10-9

Botulinum Toxin-A in Dystonia

Pediatric Neurology Briefs

Volume 4 (1990): Issue 10

By: J Gordon Millichap

Open Access

|Oct 1990

Abstract

A report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology concludes that local injection of type A botulinum toxin (Botox) is proven as a safe and efficacious modality for the treatment of blepharospasm, cervical dystonia, and hemifacial spasm.

References

Van den Noort S Assessment: the clinical usefulness of botulinum toxin-A in treating neurologic disorders. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology Neurology 1990 Sep 40 9 1332 1336 10.1212/WNL.40.9.1332 2202925
Open DOI Search in Google Scholar Back to article
Snow BJ Tsui JK Bhatt MH Varelas M Hashimoto SA Calne DB Treatment of spasticity with botulinum toxin: a double-blind study Ann Neurol 1990 Oct 28 4 512 515 10.1002/ana.410280407 2252363
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-4-10-9 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 78 - 78

Published on: Oct 1, 1990

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Efficacious Modality,

Muscle Paralysis,

Transient Lasting

© 1990 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 4 (1990): Issue 10